Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bumrungrad Hospital PCLBUGDF 97 Future 3-5Y EPS without NRI Growth Rate is 5.52 as of Sep. 12, 2026. GuruFocus rates BUGDF with a GF Score™ of 97/100 and a GF Value™ of $4.76. The stock has 3 warning signs investors should review. Among 201 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks worse than 90.05% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Bumrungrad Hospital PCL Future 3-5Y EPS without NRI Growth Rate Related Terms
BUGDF vs HCA, THC, EHC: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 5.52 mean?
Bumrungrad Hospital PCL (BUGDF) has a Future 3-5Y EPS without NRI Growth Rate of 5.52 as of Sep. 12, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Bumrungrad Hospital PCL and its competitors. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #181 out of 201 companies in the Healthcare Providers & Services industry, placing it in the top 90%.
Is Bumrungrad Hospital PCL's Future 3-5Y EPS without NRI Growth Rate too high?
Bumrungrad Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 5.52. The Healthcare Providers & Services industry median Future 3-5Y EPS without NRI Growth Rate is 17.35. Bumrungrad Hospital PCL's value of 5.52 is 68.2% below this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #181 out of 201 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Bumrungrad Hospital PCL has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Future 3-5Y EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #181 out of 201 companies for Future 3-5Y EPS without NRI Growth Rate. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 17.35. Bumrungrad Hospital PCL's value of 5.52 is 68.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y EPS without NRI Growth Rate among Healthcare Providers & Services companies is 17.35, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate of 5.52 is 68.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y EPS without NRI Growth Rate is 17.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Future 3-5Y EPS without NRI Growth Rate of 5.52. The stock's GF Value™ is $4.76, compared to a current price of $4.75 — trading 0.2% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 5.52 and 68.2% below the Healthcare Providers & Services industry median of 17.35. Bumrungrad Hospital PCL's overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Future 3-5Y EPS without NRI Growth Rate is 5.52 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 0.2% below its estimated GF Value™ of $4.76.
Key valuation signals for BUGDF:
Future 3-5Y EPS without NRI Growth Rate: 5.52
GF Value™: $4.76 vs. price of $4.75 (0.2% below fair value)
Industry Position: 68.2% below the Healthcare Providers & Services median (#181 of 201)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
97GF Score
Get the complete analysis for BUGDF
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
